As of 2026-09-16, the Relative Valuation of Rubius Therapeutics Inc (RUBY) is (77.12) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.08 USD, the upside of Rubius Therapeutics Inc based on Relative Valuation is -93021.5%.
The range of the Relative Valuation is (67.43) - (85.95) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 23.2x - 29.7x | 26.4x |
| Forward P/E multiples | 23.3x - 30.4x | 26.8x |
| Fair Price | (67.43) - (85.95) | (77.12) |
| Upside | -81340.9% - -103656.0% | -93021.5% |
| Date | P/E |